OPKO Health, Inc. (OPK) vs GeneDx Holdings Corp. (WGS)
OPKO Health, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. GeneDx Holdings Corp. is the larger, with a market value of $2.6B against $1.2B — 2.1× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against −11.5%. OPKO Health, Inc. has the higher net margin (−12.4% vs −23.4%) and the higher return on invested capital (−2.45% vs −27.7%). Across the 18 metrics below, OPKO Health, Inc. leads on 10 and GeneDx Holdings Corp. on 8.
Valuation
Profitability
| Metric | OPK | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 40.77% | 69.37% | 50.89% |
| Operating margin | (8.21%) | (20.34%) | (8.57%) |
| Net margin | (12.40%) | (23.40%) | (6.37%) |
| Free cash flow margin | (22.75%) | (16.68%) | 0.00% |
| Return on equity | (5.88%) | (40.80%) | (2.92%) |
| Return on assets | (3.83%) | (22.50%) | (6.71%) |
| Return on invested capital | (2.45%) | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack